The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration

Journal:

Nature Communications

Published:

2025-10-20

DOI:

10.1038/s41467-025-65180-6

Affiliations:

21

Authors:

45

Go to article

Institutions	Authors	Share
University Hospital of Regensburg (UKR), Germany	18.833333 18.833333	0.42
Leibniz Institute for Immunotherapy (LIT), Germany	7.833333	0.17
TUM University Hospital Klinikum rechts der Isar (MRI), Germany	4.500000	0.10
University Hospital of Erlangen, FAU, Germany	4.000000	0.09
University of Regensburg (UR), Germany	3.500000	0.08
Technical University of Munich (TUM), Germany	3.333333	0.07
DKTK Partner Site Munich, Germany	0.583333	0.01
Bavarian Cancer Research Center (BZKF), Germany	0.583333	0.01
German Oncology Center (GOC), Cyprus	0.500000	0.01
University Medical Center Freiburg, Germany	0.500000	0.01
University of Freiburg (Uni Freiburg), Germany	0.500000	0.01
German Consortium of Translational Cancer Research (DKTK), Germany	0.333333	0.01

Interested in Clinical Sciences?